Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,664,519	$ 889,900
Trade accounts receivable, less allowance for credit losses (2024 – $2,161; 2023 – $2,808)	749,792	1,213,160
Other accounts receivable	268,696	509,097
Inventories	1,657,688	2,161,287
Other current assets	328,915	443,475
Total current assets	4,669,610	5,216,919
Property, plant and equipment, at cost	12,376,369	12,233,757
Less accumulated depreciation and amortization	3,117,917	2,738,553
Net property, plant and equipment	9,258,452	9,495,204
Investments	1,179,598	1,369,855
Other assets	463,690	297,087
Goodwill	1,637,758	1,629,729
Other intangibles, net of amortization	246,078	261,858
Total assets	17,455,186	18,270,652
Current liabilities:
Accrued expenses	513,122	544,835
Current portion of long-term debt	3,012	625,761
Dividends payable	61,262	46,666
Income taxes payable	110,514	255,155
Total current liabilities	1,910,720	3,560,462
Long-term debt	3,565,990	3,541,002
Postretirement benefits	25,959	26,247
Pension benefits	143,666	150,312
Other noncurrent liabilities	791,823	769,100
Deferred income taxes	526,367	558,430
Commitments and contingencies (Note 7)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, authorized – 275,000, issued and outstanding – 117,538 in 2024 and 117,356 in 2023	1,176	1,174
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2024 and 0 in 2023	2,235,105	0
Additional paid-in capital	2,978,387	2,952,517
Accumulated other comprehensive loss	(469,770)	(528,526)
Retained earnings	5,495,697	6,987,015
Total Albemarle Corporation shareholders’ equity	10,240,595	9,412,180
Noncontrolling interests	250,066	252,919
Total equity	10,490,661	9,665,099
Total liabilities and equity	17,455,186	18,270,652
Nonrelated Party
Current liabilities:
Accounts payable	1,070,717	1,537,859
Related Party
Current liabilities:
Accounts payable	$ 152,093	$ 550,186